5,0
19 mrt 2021
Anonieme werknemer
Voormalige werknemer, meer dan 1 jaar
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Because the company is so small, there's opportunity for recent grads to get experience in the different aspects of taking a problem like resistance to immunotherapy, from a treatment idea to clinical trials and submission to the FDA. It's a very collaborative work environment and great for somebody that's eager to learn.
Minpunten
Currently still in startup phase so the future of the company relies on investor funding